Would you like to receive our publications?
|
Featured Article
| 
|
Addressing Language Barriers in Russian Clinical Trials
As the biopharmaceutical industry increasingly expands into emerging
regions, current trends in the growth of Russia's clinical research
sector are expected to continue.
Read more...
|
|
|
Dear Colleagues,
Welcome to our July issue of "Science Speaks"!
This month's topics will include an extract of our recently published article about clinical trials in South Korea, the biologics manufacturing industry in India, as well as a note from company president Leo Galperin about his recent trip to Washington, D.C., for the 2010 DIA and Global Health meetings.
We are also very excited to unveil our new and improved Language Connections website, which should answer all of your questions about our company's services. Visit us at www.languageconnections.com!
As
your team of expert language service providers, we look forward to
doing business with you. Please feel free to contact us with any
questions or requests.
Enjoy!
|
|
Clinical Trials in South Korea
|  The pharmaceutical
industry has turned to outsourcing clinical research to emerging markets to
help reduce drug development costs. Several new Asian markets have emerged as
promising clinical trial locations because they do not have the problems
associated with clinical research in more established regions. Along with greater
market opportunity, South
Korea's strong infrastructure, highly
trained clinical research personnel, and increased western collaboration have played
a significant role in the country's growth in outsourced clinical trials.
Read more...
|
|
Biologics Manufacturing in India
|  Offshoring biologics manufacturing trends in India
have taken a new route, as a result of the demand for increased biologic
production at lower costs, emphasizing greater collaboration with Western
companies. Several challenges associated with offshoring biologics
manufacturing to India
remain, including regulatory issues, inadequate IP protection, and barriers
associated with the many regional languages and cultures in the country.
Read more... |
Language Connections Attends 2010 DIA Meeting
| A note from company president, Leo Galperin:
"Earlier in June, I had the opportunity to attend the 46th Drug Information Association
Annual Meeting in Washington,
D.C. At the meeting, I delivered
a poster presentation to fellow attendees entitled "Addressing Linguistic
and Cultural Barriers in Global Clinical Trials", which discussed the
critical  importance of localization and high quality language services when
working in the Biotech and Life Science Industries. The meeting had an
impressive turnout, and provided a great setting and opportunity to meet
individuals who expressed their own thoughts about the topic, as well as their
translation or interpreting needs. I welcome any further questions or comments
about my experience at the DIA meeting, both from those who were also in
attendance, and from those who would like to learn more about the meeting and
our company..."
Read More...
|
|
We are pleased to share our newsletter with you. If you have any inquiries, comments, or suggestions, please contact us.
Sincerely,
Leo Galperin, President
Language Connections
Boston, MA
Tel. 617-731-3510
www.languageconnections.com
Wherever you do business, we speak the language.
|
|
|
